Data search
Results for MligTC455_36197
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_36197 | 92 | 1.91 | Mlig455_053513 | Neo: - |
TNS1 | Mlig455_053513 {REF} {Length: 3575} {Pfam: Phosphotyrosine-binding domain [PF08416.15, score=47.7]; SH2 domain [PF00017.26, score=40.2]} {Human: ENSG00000079308, TNS1, tensin 1, [Score=177, Expect=7e-45]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [Score=176, Expect=8e-45]; ENSMUSG00000020422, Tns3, tensin 3, [Score=169, Expect=9e-43]} {Dmel: FBgn0000244, by, blistery, [Score=166, Expect=2e-42]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=181, Expect=5e-51]} {Smed: dd_Smed_v6_4494_0_2, dd_Smed_v6_4494_0_2, [Score=181, Expect=5e-48]} {RNA1509_28824, RNA1509_50496} {RNA1310_7318, RNA1509_28824, RNA1509_50496} {RNA1509_28824, RNA1509_50496, RNA815_6926} |
Cumulative graph for MligTC455_36197
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -5.021 | 1.713 | 0.29250 | 0.94460 | |
| RegionR2 | 1.521 | 1.713 | 0.18516 | 0.53736 | |
| RegionR3 | 0.486 | 1.713 | 0.60518 | 1.00000 | |
| RegionR4 | -0.762 | 1.713 | 0.98040 | 1.00000 | |
| RegionR5 | -1.06 | 1.713 | 0.99002 | 1.00000 | |
| RegionR6 | 0.263 | 1.713 | 0.74659 | 1.00000 | |
| RegionR7 | 2.052 | 1.713 | 0.05324 | 0.44338 | |
| RegionR8 | 2.521 | 1.713 | 0.03113 | 0.34441 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 2.413 | 1.713 | 0.99982 | 1.00000 | |
| RegenerationR2 | 0.877 | 1.713 | 0.22578 | 0.67383 | |
| RegenerationR3 | 1.083 | 1.713 | 0.18635 | 0.62265 | |
| RegenerationR4 | 0.413 | 1.713 | 0.65419 | 0.93519 | |
| RegenerationR5 | 0.374 | 1.713 | 0.67280 | 0.94214 | |
| RegenerationR6 | 1.31 | 1.713 | 0.15475 | 0.48112 | |
| RegenerationBL | 0.537 | 1.713 | 0.61902 | 0.96199 | |
| RegenerationTP | 0.1 | 1.713 | 0.87126 | 1.00000 |
Genes with expression patterns similar to MligTC455_36197
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_36197 | 92 | 1.91 | Mlig455_053513 | Neo: - |
TNS1 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_053513 {REF} {Length: 3575} {Pfam: Phosphotyrosine-binding domain [PF08416.15, score=47.7]; SH2 domain [PF00017.26, score=40.2]} {Human: ENSG00000079308, TNS1, tensin 1, [Score=177, Expect=7e-45]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [Score=176, Expect=8e-45]; ENSMUSG00000020422, Tns3, tensin 3, [Score=169, Expect=9e-43]} {Dmel: FBgn0000244, by, blistery, [Score=166, Expect=2e-42]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=181, Expect=5e-51]} {Smed: dd_Smed_v6_4494_0_2, dd_Smed_v6_4494_0_2, [Score=181, Expect=5e-48]} {RNA1509_28824, RNA1509_50496} {RNA1310_7318, RNA1509_28824, RNA1509_50496} {RNA1509_28824, RNA1509_50496, RNA815_6926} |
| 2. | MligTC455_36198 | 102 | 2.13 | Mlig455_061010 | Neo: - Age: - |
TNS1 | 4.901 | 0.985 | 0.991 | - | 0.931 | 0.996 | 0.998 | Mlig455_061010 {REF} {Length: 1601} {Pfam: Phosphotyrosine-binding domain [PF08416.15, score=49.9]; SH2 domain [PF00017.26, score=30.3]} {Human: ENSG00000079308, TNS1, tensin 1, [Score=155, Expect=5e-42]; ENSG00000136205, TNS3, tensin 3, [Score=151, Expect=2e-40]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [Score=155, Expect=2e-42]; ENSMUSG00000020422, Tns3, tensin 3, [Score=154, Expect=1e-41]} {Dmel: FBgn0000244, by, blistery, [Score=150, Expect=8e-41]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=164, Expect=2e-48]} {Smed: dd_Smed_v6_4454_0_5, dd_Smed_v6_4454_0_5, [Score=153, Expect=5e-45]} {RNA1509_28824} {RNA1310_20281} {RNA815_21042} |
| 3. | MligTC455_36309 | 659 | 13.73 | Mlig455_000959 | Neo: - Age: - |
1.825 | 0.972 | - | - | - | - | 0.853 | Mlig455_000959 {REF} {Length: 2183} {Pfam: PH domain [PF00169.31, score=24.8]} {RNA1509_27870} {RNA1310_17063.3} {RNA815_9359.1} | |
| 4. | MligTC455_39971 | 147 | 3.07 | Mlig455_034549 | Neo: - Age: - Region-enriched R8: 4.475/0.00030 |
1.816 | 0.842 | - | 0.974 | - | - | - | Mlig455_034549 {REF} {Length: 2181} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.7]} {RNA1310_27858} {RNA815_17949} | |
| 5. | MligTC455_39972 | 142 | 2.96 | Mlig455_064814 | Neo: - Age: - Region-enriched R8: 4.539/0.00054 |
1.811 | 0.842 | - | 0.969 | - | - | - | Mlig455_064814 {REF} {Length: 2232} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=34.6]} {RNA1310_27858} {RNA815_17949} | |
| 6. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 1.797 | 0.833 | - | 0.964 | - | - | - | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
| 7. | MligTC455_44031 | 16 | 0.33 | Mlig455_018450 | Neo: - Age: - |
1.751 | - | - | 0.989 | - | 0.762 | - | Mlig455_018450 {REF} {Length: 381} {NoTransDecoderORF} {RNA1509_54874} {RNA1310_80775} {RNA815_15576} | |
| 8. | MligTC455_47805 | 309 | 6.43 | Mlig455_002866, Mlig455_033201 | Neo: - |
NR2C2 | 1.702 | - | - | - | 0.739 | 0.963 | - | Mlig455_002866 {REF} {Length: 2397} {RNA1509_25172} {RNA1310_17963.1} {RNA815_11681} Mlig455_033201 {REF} {Length: 2405} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=86.4]} {Human: ENSG00000177463, NR2C2, nuclear receptor subfamily 2 group C member 2, [Score=90.5, Expect=1e-18]; ENSG00000120798, NR2C1, nuclear receptor subfamily 2 group C member 1, [Score=87.8, Expect=4e-18]; ENSG00000101076, HNF4A, hepatocyte nuclear factor 4 alpha, [Score=87.4, Expect=7e-18]; ENSG00000113580, NR3C1, nuclear receptor subfamily 3 group C member 1, [Score=87.4, Expect=2e-17]; ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [Score=87.0, Expect=6e-18]; ENSG00000160113, NR2F6, nuclear receptor subfamily 2 group F member 6, [Score=86.7, Expect=9e-18]; ENSG00000151623, NR3C2, nuclear receptor subfamily 3 group C member 2, [Score=86.7, Expect=3e-17]} {Mouse: ENSMUSG00000005893, Nr2c2, nuclear receptor subfamily 2, group C, member 2, [Score=88.2, Expect=5e-18]; ENSMUSG00000017950, Hnf4a, hepatic nuclear factor 4, alpha, [Score=88.2, Expect=3e-18]; ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [Score=87.0, Expect=5e-18]; ENSMUSG00000031618, Nr3c2, nuclear receptor subfamily 3, group C, member 2, [Score=87.0, Expect=1e-17]; ENSMUSG00000005897, Nr2c1, nuclear receptor subfamily 2, group C, member 1, [Score=86.7, Expect=1e-17]; ENSMUSG00000002393, Nr2f6, nuclear receptor subfamily 2, group F, member 6, [Score=85.9, Expect=9e-18]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [Score=85.1, Expect=2e-17]; ENSMUSG00000023034, Nr4a1, nuclear receptor subfamily 4, group A, member 1, [Score=85.1, Expect=4e-17]; ENSMUSG00000024431, Nr3c1, nuclear receptor subfamily 3, group C, member 1, [Score=85.1, Expect=5e-17]; ENSMUSG00000026398, Nr5a2, nuclear receptor subfamily 5, group A, member 2, [Score=84.3, Expect=7e-17]} {Dmel: FBgn0264562, Hr4, Hormone receptor 4, [Score=96.3, Expect=1e-20]} {Celegans: WBGene00003681, nhr-91, Nuclear hormone receptor family member nhr-91, [Score=89.7, Expect=5e-19]} {Smed: dd_Smed_v6_33286_0_2, dd_Smed_v6_33286_0_2, [Score=86.7, Expect=6e-19]} {RNA1509_25172} {RNA1310_17963.1, RNA1509_25172} {RNA1509_25172, RNA815_11681} |
| 9. | MligTC455_13986 | 12 | 0.25 | Mlig455_025214 | Neo: - Age: - |
IRX5 | 0.997 | - | - | 0.997 | - | - | - | Mlig455_025214 {REF} {Length: 2473} {Pfam: Homeobox KN domain [PF05920.13, score=56.2]; Homeodomain [PF00046.31, score=31.8]} {Human: ENSG00000176842, IRX5, iroquois homeobox 5, [Score=139, Expect=6e-37]; ENSG00000159387, IRX6, iroquois homeobox 6, [Score=135, Expect=6e-36]} {Mouse: ENSMUSG00000031737, Irx5, Iroquois homeobox 5, [Score=136, Expect=5e-36]; ENSMUSG00000031738, Irx6, Iroquois homeobox 6, [Score=135, Expect=8e-36]; ENSMUSG00000021604, Irx4, Iroquois homeobox 4, [Score=130, Expect=1e-33]; ENSMUSG00000060969, Irx1, Iroquois homeobox 1, [Score=130, Expect=4e-34]; ENSMUSG00000031734, Irx3, Iroquois related homeobox 3, [Score=130, Expect=6e-34]; ENSMUSG00000001504, Irx2, Iroquois homeobox 2, [Score=130, Expect=9e-34]} {Dmel: FBgn0015904, ara, araucan, [Score=133, Expect=2e-34]} {Celegans: WBGene00007984, irx-1, Putative iroquois-class homeodomain protein irx-1, [Score=111, Expect=9e-28]} {Smed: dd_Smed_v6_17352_0_1, dd_Smed_v6_17352_0_1, [Score=148, Expect=2e-41]} {RNA1310_51494.1} {RNA815_48813} |
| 10. | MligTC455_21781 | 18 | 0.37 | Mlig455_000405, Mlig455_000474 | Neo: - Age: Up-Up-Down |
0.997 | - | - | 0.997 | - | - | - | Mlig455_000405 {REF} {Length: 4189} {Pfam: Pao retrotransposon peptidase [PF05380.15, score=109.0]; Integrase zinc binding domain [PF17921.3, score=33.8]} {Smed: dd_Smed_v6_17391_0_1, dd_Smed_v6_17391_0_1, [RH, Score=57.4, Expect=3e-10]} {RNA1509_53267} {RNA1310_6178} {RNA815_31262} Mlig455_000474 {REF} {Length: 1522} {Pfam: Family of unknown function (DUF5641) [PF18701.3, score=112.0]} {Smed: dd_Smed_v6_22202_0_1, dd_Smed_v6_22202_0_1, [Score=105, Expect=2e-28]} {RNA1310_18148.2} {RNA815_46086} |
|
| 11. | MligTC455_00744 | 5 | 0.11 | Mlig455_027706 | Neo: - Age: - |
0.994 | - | - | - | - | 0.994 | - | Mlig455_027706 {REF} {Length: 520} {NoTransDecoderORF} {RNA1310_47876.2} {RNA815_62057} | |
| 12. | MligTC455_36784 | 15 | 0.3 | Mlig455_046783, Mlig455_069957 | Neo: - Age: logFC(26M/2M)=-0.515 |
0.993 | - | - | - | - | 0.993 | - | Mlig455_046783 {REF} {Length: 1605} {RNA1509_14365} {RNA1310_13117.2} {RNA815_6458.1} Mlig455_069957 {REF} {Length: 1377} {RNA1509_14365} {RNA1310_13117.4} {RNA815_6458.1} |
|
| 13. | MligTC455_47411 | 30 | 0.62 | Mlig455_038925, Mlig455_039034 | Neo: - Age: logFC(26M/2M)=-0.685 |
0.983 | - | - | 0.983 | - | - | - | Mlig455_038925 {REF} {Length: 941} {NoTransDecoderORF} {RNA1509_9488} {RNA1310_1542.1} {RNA815_3130} Mlig455_039034 {REF} {Length: 1791} {RNA1509_9488} {RNA1310_1542.1} {RNA815_3130} |
|
| 14. | MligTC455_36274 | 15 | 0.31 | Mlig455_008085 | Neo: - Age: - |
0.981 | - | - | - | - | 0.981 | - | Mlig455_008085 {REF} {Length: 2167} {NoTransDecoderORF} {RNA1509_32205} {RNA1310_64038} {RNA815_49379} | |
| 15. | MligTC455_17759 | 25 | 0.53 | Mlig455_032815 | Neo: - Age: Up-Up-Down |
0.98 | - | - | - | - | 0.980 | - | Mlig455_032815 {REF} {Length: 1891} {Pfam: Protein of unknown function (DUF2673) [PF10880.10, score=53.5]} {RNA1509_57582} {RNA1310_49538.1, RNA1509_57582} | |
| 16. | MligTC455_37115 | 143 | 2.97 | Mlig455_020761 | Neo: - Age: - |
CA10 | 0.98 | - | - | 0.980 | - | - | - | Mlig455_020761 {REF} {Length: 2633} {Pfam: Eukaryotic-type carbonic anhydrase [PF00194.23, score=197.9]} {Human: ENSG00000154975, CA10, carbonic anhydrase 10, [RH, Score=193, Expect=1e-58]} {Mouse: ENSMUSG00000056158, Car10, carbonic anhydrase 10, [RH, Score=193, Expect=8e-59]} {Dmel: FBgn0029962, CG1402, [RH, Score=196, Expect=6e-60]} {Celegans: WBGene00000279, cah-1, Carbonic AnHydrase, [RH, Score=178, Expect=1e-53]} {Smed: dd_Smed_v6_15243_0_1, dd_Smed_v6_15243_0_1, [RH, Score=296, Expect=2e-99]} {RNA1509_19317} {RNA1310_15609, RNA1509_19317} {RNA1509_19317, RNA815_6866} |
| 17. | MligTC455_40364 | 19 | 0.4 | Mlig455_038354 | Neo: - Age: - |
0.978 | - | - | 0.978 | - | - | - | Mlig455_038354 {REF} {Length: 2608} {RNA1509_57598} {RNA1310_48414} {RNA815_41099} | |
| 18. | MligTC455_50866 | 73 | 1.53 | Mlig455_052918 | Neo: Int S/G2/M Age: - |
0.975 | - | - | - | - | 0.975 | - | Mlig455_052918 {REF} {Length: 3299} {RNA1509_20768} {RNA1310_18267} {RNA815_37080} | |
| 19. | MligTC455_11966 | 21 | 0.44 | Mlig455_048087 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_048087 {REF} {Length: 791} {RNA1509_15570} {RNA1310_9037} {RNA815_62132} | |
| 20. | MligTC455_54150 | 45 | 0.93 | Mlig455_040594 | Neo: - Age: - |
0.974 | - | - | 0.974 | - | - | - | Mlig455_040594 {REF} {Length: 2865} {TRANSSPLICED} {RNA1310_34799.1} {RNA815_13806} | |
| 21. | MligTC455_01648 | 4 | 0.08 | Mlig455_065106 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_065106 {REF} {Length: 495} {NoTransDecoderORF} {RNA1310_110067} {RNA815_57749} | |
| 22. | MligTC455_12397 | 18 | 0.37 | Mlig455_021272 | Neo: - Age: - |
SCNN1G | 0.969 | - | - | 0.969 | - | - | - | Mlig455_021272 {REF} {Length: 2377} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=191.3]} {Human: ENSG00000166828, SCNN1G, sodium channel epithelial 1 gamma subunit, [Score=52.0, Expect=3e-06]} {Mouse: ENSMUSG00000000216, Scnn1g, sodium channel, nonvoltage-gated 1 gamma, [Score=49.7, Expect=1e-05]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=70.1, Expect=3e-12]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=103, Expect=7e-23]} {RNA1310_124026} |
| 23. | MligTC455_19124 | 68 | 1.41 | Mlig455_056714 | Neo: - Age: Up-Down-Up |
NPFFR1 | 0.969 | - | - | 0.969 | - | - | - | Mlig455_056714 {REF} {Length: 3702} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=113.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.3]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=90.1, Expect=1e-18]; ENSG00000137252, HCRTR2, hypocretin receptor 2, [Score=87.8, Expect=6e-18]} {Mouse: ENSMUSG00000038071, Npy6r, neuropeptide Y receptor Y6, [Score=105, Expect=2e-24]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=131, Expect=7e-33]} {Celegans: WBGene00003808, npr-2, NeuroPeptide Receptor family, [Score=100, Expect=1e-22]} {Smed: dd_Smed_v6_26109_0_1, dd_Smed_v6_26109_0_1, [RH, Score=210, Expect=4e-61]} {RNA1509_34547} {RNA1310_9062, RNA1509_34547} {RNA1509_34547, RNA815_6805} |
| 24. | MligTC455_25562 | 10 | 0.21 | Mlig455_042405 | Neo: - Age: - |
KREMEN2 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_042405 {REF} {Length: 2000} {TRANSSPLICED} {Pfam: WSC domain [PF01822.21, score=47.2]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=48.1, Expect=5e-06]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=6e-06]} {RNA1509_39834} {RNA1310_29401} {RNA815_27180} |
| 25. | MligTC455_13329 | 95 | 1.98 | Mlig455_009198 | Neo: - |
0.963 | - | - | - | - | - | 0.963 | Mlig455_009198 {REF} {Length: 2007} {RNA1509_22077, RNA1509_32545} {RNA1310_29047.1, RNA1509_22077, RNA1509_32545} {RNA1509_22077, RNA1509_32545, RNA815_17550} | |
| 26. | MligTC455_20332 | 34 | 0.71 | Mlig455_038515 | Neo: - Age: - |
0.963 | - | - | 0.963 | - | - | - | Mlig455_038515 {REF} {Length: 2092} {RNA1509_52468} {RNA1310_41235} {RNA815_11414.1} | |
| 27. | MligTC455_29853 | 45 | 0.94 | Mlig455_026579, Mlig455_044780, Mlig455_054135 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_026579 {REF} {Length: 430} {RNA1310_43414} Mlig455_044780 {REF} {Length: 430} {RNA1310_43414} Mlig455_054135 {REF} {Length: 4050} {Pfam: Transcriptional Coactivator p15 (PC4) [PF02229.18, score=27.4]} {RNA1509_13774} {RNA1310_6053.2} {RNA815_16908} |
|
| 28. | MligTC455_31325 | 78 | 1.62 | Mlig455_026709, Mlig455_044580, Mlig455_050736, Mlig455_050745 | Neo: - Age: - |
0.962 | - | - | - | 0.962 | - | - | Mlig455_026709 {REF} {Length: 5107} {TRANSSPLICED} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=119.6]; Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=19.1]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=65.1, Expect=2e-12]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} Mlig455_044580 {REF} {Length: 2183} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=80.6]} {RNA1509_47056} {RNA1310_3828} {RNA815_6291.1} Mlig455_050736 {REF} {Length: 1564} {TRANSSPLICED} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=121.6]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=65.9, Expect=7e-13]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_15609} Mlig455_050745 {REF} {Length: 1565} {TRANSSPLICED} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=121.6]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=65.9, Expect=7e-13]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_15609} |
|
| 29. | MligTC455_35375 | 97 | 2.02 | Mlig455_000108, Mlig455_056118, Mlig455_056902, Mlig455_061600, Mlig455_066534 | Neo: - Age: - |
0.962 | - | - | 0.962 | - | - | - | Mlig455_000108 {REF} {Length: 627} {NoTransDecoderORF} {RNA1509_47429} {RNA1310_22662.1} {RNA815_42886} Mlig455_056118 {REF} {Length: 627} {NoTransDecoderORF} {RNA1509_47429} {RNA1310_22662.1} {RNA815_42886} Mlig455_056902 {REF} {Length: 628} {NoTransDecoderORF} {RNA1509_47429} {RNA1310_22662.1} {RNA815_42886} Mlig455_061600 {REF} {Length: 823} {NoTransDecoderORF} {RNA1509_47429} {RNA1310_22662.1} {RNA815_42886} Mlig455_066534 {REF} {Length: 672} {NoTransDecoderORF} {RNA1509_47429} {RNA1310_22662.1} {RNA815_42886} |
|
| 30. | MligTC455_57417 | 27 | 0.56 | Mlig455_045382 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_045382 {REF} {Length: 268} {NoTransDecoderORF} | |
| 31. | MligTC455_33697 | 164 | 3.42 | Mlig455_003757, Mlig455_003917 | Neo: - Age: - |
HNRNPLL | 0.959 | - | - | 0.959 | - | - | - | Mlig455_003757 {REF} {Length: 2618} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=106.7]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=83.2]; Protein of unknown function (DUF4523) [PF15023.8, score=19.3]} {Human: ENSG00000143889, HNRNPLL, heterogeneous nuclear ribonucleoprotein L like, [Score=166, Expect=4e-44]} {Mouse: ENSMUSG00000024095, Hnrnpll, heterogeneous nuclear ribonucleoprotein L-like, [Score=167, Expect=5e-44]} {Dmel: FBgn0003435, sm, smooth, [Score=146, Expect=1e-37]} {Celegans: WBGene00016624, C44B7.2, [Score=174, Expect=8e-47]} {Smed: dd_Smed_v6_1327_0_1, dd_Smed_v6_1327_0_1, [Score=166, Expect=3e-44]} {RNA1509_16405} {RNA1310_13427} {RNA815_7500.1} Mlig455_003917 {REF} {Length: 2960} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=116.7]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=86.9]} {Human: ENSG00000143889, HNRNPLL, heterogeneous nuclear ribonucleoprotein L like, [Score=178, Expect=5e-48]} {Mouse: ENSMUSG00000024095, Hnrnpll, heterogeneous nuclear ribonucleoprotein L-like, [Score=178, Expect=5e-48]} {Dmel: FBgn0003435, sm, smooth, [Score=145, Expect=3e-37]} {Celegans: WBGene00016624, C44B7.2, [Score=179, Expect=2e-48]} {Smed: dd_Smed_v6_1327_0_1, dd_Smed_v6_1327_0_1, [Score=174, Expect=3e-47]} {RNA1509_16405} {RNA1310_13427} {RNA815_7500.1} |
| 32. | MligTC455_24682 | 17 | 0.36 | Mlig455_071042 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_071042 {REF} {Length: 5149} {RNA1509_34740} {RNA1310_6113.1} {RNA815_6593} | |
| 33. | MligTC455_54019 | 59 | 1.23 | Mlig455_050979 | Neo: - Age: logFC(26M/2M)=0.902 |
DEGS2 | 0.958 | - | - | 0.958 | - | - | - | Mlig455_050979 {REF} {Length: 2343} {Pfam: Fatty acid desaturase [PF00487.26, score=84.5]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=59.9]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=332, Expect=1e-111]} {Mouse: ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=320, Expect=3e-107]; ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=304, Expect=8e-101]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=354, Expect=1e-120]} {Celegans: WBGene00013197, ttm-5, Putative sphingolipid delta(4)-desaturase/C4-monooxygenase, [Score=325, Expect=1e-108]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=422, Expect=6e-147]} {RNA1509_11966, RNA1509_33417, RNA1509_59878} {RNA1310_11518, RNA1509_11966, RNA1509_33417, RNA1509_59878} {RNA1509_11966, RNA1509_33417, RNA1509_59878, RNA815_6718} |
| 34. | MligTC455_01226 | 14 | 0.3 | Mlig455_018203 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_018203 {REF} {Length: 673} {NoTransDecoderORF} {RNA1509_35533} {RNA1310_93416} {RNA815_17588} | |
| 35. | MligTC455_25597 | 15 | 0.32 | Mlig455_042454 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_042454 {REF} {Length: 1742} {NoTransDecoderORF} {RNA1310_68055} | |
| 36. | MligTC455_30389 | 116 | 2.41 | Mlig455_029602 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_029602 {REF} {Length: 2395} {RNA1509_16871} {RNA1310_10374.1} {RNA815_9291} | |
| 37. | MligTC455_36850 | 102 | 2.12 | Mlig455_061130 | Neo: - Age: - |
RHBDF2 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_061130 {REF} {Length: 6350} {TRANSSPLICED} {Pfam: Rhomboid family [PF01694.24, score=74.1]} {Human: ENSG00000129667, RHBDF2, rhomboid 5 homolog 2, [RH, Score=362, Expect=7e-112]; ENSG00000007384, RHBDF1, rhomboid 5 homolog 1, [RH, Score=360, Expect=5e-111]} {Mouse: ENSMUSG00000020806, Rhbdf2, rhomboid 5 homolog 2, [RH, Score=366, Expect=1e-113]} {Dmel: FBgn0041723, rho-5, rhomboid-5, [RH, Score=309, Expect=2e-89]} {Celegans: WBGene00004403, rom-4, Rhomboid-like protein, [RH, Score=313, Expect=2e-91]} {Smed: dd_Smed_v6_11534_0_2, dd_Smed_v6_11534_0_2, [RH, Score=410, Expect=3e-132]} {RNA1509_18207} {RNA1310_7108} {RNA815_9193} |
| 38. | MligTC455_01448 | 15 | 0.31 | Mlig455_063614 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_063614 {REF} {Length: 27} {TRANSSPLICED} {NoTransDecoderORF} | |
| 39. | MligTC455_24612 | 12 | 0.25 | Mlig455_000425, Mlig455_000489, Mlig455_000526, Mlig455_024858 | Neo: - Age: - |
SCN1A | 0.951 | - | - | - | - | 0.951 | - | Mlig455_000425 {REF} {Length: 2186} {Pfam: Ion transport protein [PF00520.33, score=296.1]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.9]; Polycystin cation channel [PF08016.14, score=23.2]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=502, Expect=4e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=498, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=490, Expect=7e-153]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=486, Expect=2e-151]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=486, Expect=9e-152]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=481, Expect=1e-149]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=481, Expect=4e-150]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=500, Expect=7e-157]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=494, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=490, Expect=4e-153]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=484, Expect=2e-151]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=484, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=483, Expect=1e-150]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=481, Expect=5e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=475, Expect=6e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=538, Expect=2e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=189, Expect=6e-50]} {Smed: dd_Smed_v6_13973_0_1, dd_Smed_v6_13973_0_1, [Score=610, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_000489 {REF} {Length: 2384} {Pfam: Ion transport protein [PF00520.33, score=296.0]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.7]; Polycystin cation channel [PF08016.14, score=23.0]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=504, Expect=4e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=501, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=492, Expect=9e-153]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=489, Expect=1e-151]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=488, Expect=2e-151]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=483, Expect=9e-150]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=482, Expect=8e-150]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=479, Expect=4e-148]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=502, Expect=1e-156]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=496, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=493, Expect=2e-153]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=487, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=486, Expect=1e-150]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=486, Expect=4e-151]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=483, Expect=6e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=478, Expect=7e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=541, Expect=1e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=191, Expect=5e-50]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=627, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_000526 {REF} {Length: 2384} {Pfam: Ion transport protein [PF00520.33, score=296.7]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.7]; Polycystin cation channel [PF08016.14, score=22.9]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=503, Expect=3e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=501, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=492, Expect=8e-153]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=489, Expect=8e-152]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=488, Expect=2e-151]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=484, Expect=1e-149]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=483, Expect=6e-150]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=478, Expect=5e-148]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=502, Expect=1e-156]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=496, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=493, Expect=3e-153]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=487, Expect=4e-151]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=486, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=486, Expect=2e-150]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=484, Expect=5e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=478, Expect=7e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=541, Expect=1e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=191, Expect=6e-50]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=628, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_024858 {REF} {Length: 1954} {Pfam: Ion transport protein [PF00520.33, score=318.3]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=32.1]; Polycystin cation channel [PF08016.14, score=30.0]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=660, Expect=0.0]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=654, Expect=0.0]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=649, Expect=0.0]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=640, Expect=0.0]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=639, Expect=0.0]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=635, Expect=0.0]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=631, Expect=0.0]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=627, Expect=0.0]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=655, Expect=0.0]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=652, Expect=0.0]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=646, Expect=0.0]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=645, Expect=0.0]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=637, Expect=0.0]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=635, Expect=0.0]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=630, Expect=0.0]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=623, Expect=0.0]} {Dmel: FBgn0285944, para, paralytic, [Score=701, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=268, Expect=3e-77]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=816, Expect=0.0]} {RNA1310_51142} |
| 40. | MligTC455_27211 | 14 | 0.29 | Mlig455_024750 | Neo: - Age: Down-Up-Down |
0.951 | - | - | - | - | 0.951 | - | Mlig455_024750 {REF} {Length: 887} {NoTransDecoderORF} {RNA1509_25657} {RNA1310_15620} {RNA815_11419.1} | |
| 41. | MligTC455_44032 | 45 | 0.93 | Mlig455_052070 | Neo: - Age: - |
0.951 | - | - | 0.951 | - | - | - | Mlig455_052070 {REF} {Length: 982} {RNA1509_32990} {RNA1310_16255} {RNA815_7340} | |
| 42. | MligTC455_31793 | 17 | 0.36 | Mlig455_026274 | Neo: - Age: Up-Down-Up Region-enriched R4: 5.540/0.02199 |
TRIM3 | 0.95 | - | - | - | - | 0.950 | - | Mlig455_026274 {REF} {Length: 2070} {TRANSSPLICED} {Pfam: NHL repeat [PF01436.23, score=28.5]} {Human: ENSG00000110171, TRIM3, tripartite motif containing 3, [Score=62.0, Expect=2e-09]; ENSG00000109654, TRIM2, tripartite motif containing 2, [Score=62.0, Expect=2e-09]} {Mouse: ENSMUSG00000027993, Trim2, tripartite motif-containing 2, [Score=62.0, Expect=1e-09]; ENSMUSG00000036989, Trim3, tripartite motif-containing 3, [Score=62.0, Expect=1e-09]} {Dmel: FBgn0265356, tn, thin, [Score=57.4, Expect=3e-08]} {RNA1509_23300} {RNA1310_14145.1} {RNA815_3900.5} |
| 43. | MligTC455_33493 | 215 | 4.47 | Mlig455_047893, Mlig455_064980, Mlig455_065421, Mlig455_067916 | Neo: - Age: Up-Down-Up |
SLC30A2 | 0.95 | - | - | 0.950 | - | - | - | Mlig455_047893 {REF} {Length: 1130} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.0]} Mlig455_064980 {REF} {Length: 979} {Pfam: Cation efflux family [PF01545.23, score=57.4]; Dimerisation domain of Zinc Transporter [PF16916.7, score=24.3]} {Human: ENSG00000158014, SLC30A2, solute carrier family 30 member 2, [Score=179, Expect=7e-54]} {Mouse: ENSMUSG00000028836, Slc30a2, solute carrier family 30 (zinc transporter), member 2, [Score=185, Expect=2e-57]} {Dmel: FBgn0028516, ZnT35C, Zinc transporter 35C, [Score=162, Expect=4e-47]} {Celegans: WBGene00011821, cdf-2, Cation Diffusion Facilitator family, [Score=187, Expect=1e-57]} {Smed: dd_Smed_v6_5529_0_1, dd_Smed_v6_5529_0_1, [Score=225, Expect=2e-72]} {RNA1509_47927} {RNA1310_21629.1} {RNA815_44787} Mlig455_065421 {REF} {Length: 3516} {Pfam: Cation efflux family [PF01545.23, score=159.5]; Dimerisation domain of Zinc Transporter [PF16916.7, score=23.2]} {Human: ENSG00000158014, SLC30A2, solute carrier family 30 member 2, [Score=344, Expect=4e-116]} {Mouse: ENSMUSG00000028836, Slc30a2, solute carrier family 30 (zinc transporter), member 2, [Score=362, Expect=4e-123]} {Dmel: FBgn0028516, ZnT35C, Zinc transporter 35C, [Score=344, Expect=2e-115]} {Celegans: WBGene00012712, ttm-1, Toxin-regulated Targets of MAPK, [Score=251, Expect=2e-79]} {Smed: dd_Smed_v6_5529_0_1, dd_Smed_v6_5529_0_1, [Score=432, Expect=5e-151]} {RNA1509_47927} {RNA1310_21629.1} {RNA815_27861} Mlig455_067916 {REF} {Length: 597} {RNA1310_109975} {RNA815_48549} |